PowerShares DB G10货币嘉实基金 DBV 深沪

已收盘 03-03 16:00:00 美东时间

0.000

0.00%

华盛通

个股概要

DBV Technologies to Participate in Upcoming EAACI Congress 2025

DBV Technologies将在2025年EAACI大会上展示其VIASKIN®花生贴片的研究进展，包括减少意外花生摄入反应的数据以及针对非IgE介导牛奶过敏的第二阶段研究，研讨会将探讨epicutaneous免疫疗法的新动态。

06-12 20:05
DBV Technologies Announces the Voting Results of its 2025 Combined General Meeting

DBV Technologies' 2025 Combined General Meeting held on June 11, 2025, in Châtillon, France, resulted in shareholders approving all proposed resolutions. The company, focused on developing treatments for food allergies using its Viaskin™ platform, continues clinical trials for peanut allergies in toddlers and children.

06-11 20:30
DBV Technologies announces the filing of an addendum to the 2024 Universal Registration Document

DBV Technologies announced the filing of an addendum to its 2024 Universal Registration Document, updating the Board of Directors' Corporate Governance Report to include exceptional compensation granted to the CEO, pending approval at the Annual General Meeting on June 11, 2025. The documents are available on the Company’s and AMF’s websites.

06-03 20:30

公司名称	PowerShares DB G10货币嘉实基金
行业分类	--
业务描述	Invesco DB G10 Currency Harvest Fund operates as mutual-exchange traded fund. It seeks to track changes in the level of the Deutsche Bank G10 Currency Future Harvest Index. The Index is composed of currency futures contracts on certain G10 currencies and is designed to exploit the trend that currencies associated with relatively high interest rates, on average, tend to rise in value relative to currencies associated with relatively low interest rates. It issues common units of beneficial interest, or shares, which represent units of fractional undivided beneficial interest in and ownership. The company was founded on August 12, 2006 and is headquartered in Downers Grove, IL.